These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 28610595)

  • 1. Stem cell models of Alzheimer's disease: progress and challenges.
    Arber C; Lovejoy C; Wray S
    Alzheimers Res Ther; 2017 Jun; 9(1):42. PubMed ID: 28610595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human iPSC application in Alzheimer's disease and Tau-related neurodegenerative diseases.
    Tcw J
    Neurosci Lett; 2019 Apr; 699():31-40. PubMed ID: 30685408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human iPSC-Derived Neural Models for Studying Alzheimer's Disease: from Neural Stem Cells to Cerebral Organoids.
    Barak M; Fedorova V; Pospisilova V; Raska J; Vochyanova S; Sedmik J; Hribkova H; Klimova H; Vanova T; Bohaciakova D
    Stem Cell Rev Rep; 2022 Feb; 18(2):792-820. PubMed ID: 35107767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Pluripotent Stem Cells as In Vitro Models of Neurodegenerative Diseases.
    Machairaki V
    Adv Exp Med Biol; 2020; 1195():93-94. PubMed ID: 32468463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of cerebral organoids: a more qualified model for Alzheimer's disease research.
    Bi FC; Yang XH; Cheng XY; Deng WB; Guo XL; Yang H; Wang Y; Li J; Yao Y
    Transl Neurodegener; 2021 Aug; 10(1):27. PubMed ID: 34372927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral organoids derived from patients with Alzheimer's disease with PSEN1/2 mutations have defective tissue patterning and altered development.
    Vanova T; Sedmik J; Raska J; Amruz Cerna K; Taus P; Pospisilova V; Nezvedova M; Fedorova V; Kadakova S; Klimova H; Capandova M; Orviska P; Fojtik P; Bartova S; Plevova K; Spacil Z; Hribkova H; Bohaciakova D
    Cell Rep; 2023 Nov; 42(11):113310. PubMed ID: 37864790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse induced pluripotent stem cells-derived Alzheimer's disease cerebral organoid culture and neural differentiation disorders.
    Fan W; Sun Y; Shi Z; Wang H; Deng J
    Neurosci Lett; 2019 Oct; 711():134433. PubMed ID: 31421155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human-Induced Pluripotent Stem Cell (hiPSC)-Derived Neurons and Glia for the Elucidation of Pathogenic Mechanisms in Alzheimer's Disease.
    Young JE; Goldstein LSB
    Methods Mol Biol; 2023; 2561():105-133. PubMed ID: 36399267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's in a dish - induced pluripotent stem cell-based disease modeling.
    de Leeuw S; Tackenberg C
    Transl Neurodegener; 2019; 8():21. PubMed ID: 31338163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological manifestation of the induced pluripotent stem cell-derived cortical neurons from an early-onset Alzheimer's disease patient carrying a presenilin-1 mutation (S170F).
    Li L; Kim HJ; Roh JH; Kim M; Koh W; Kim Y; Heo H; Chung J; Nakanishi M; Yoon T; Hong CP; Seo SW; Na DL; Song J
    Cell Prolif; 2020 Apr; 53(4):e12798. PubMed ID: 32216003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's disease and synapse Loss: What can we learn from induced pluripotent stem Cells?
    Rodriguez-Jimenez FJ; Ureña-Peralta J; Jendelova P; Erceg S
    J Adv Res; 2023 Dec; 54():105-118. PubMed ID: 36646419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced Neuronal Activity and Asynchronous Calcium Transients Revealed in a 3D Organoid Model of Alzheimer's Disease.
    Yin J; VanDongen AM
    ACS Biomater Sci Eng; 2021 Jan; 7(1):254-264. PubMed ID: 33347288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Harnessing cerebral organoids for Alzheimer's disease research.
    Bubnys A; Tsai LH
    Curr Opin Neurobiol; 2022 Feb; 72():120-130. PubMed ID: 34818608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modelling Sporadic Alzheimer's Disease Using Induced Pluripotent Stem Cells.
    Rowland HA; Hooper NM; Kellett KAB
    Neurochem Res; 2018 Dec; 43(12):2179-2198. PubMed ID: 30387070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Pluripotent Stem Cell-Derived Neural Cells as a Relevant Platform for Drug Screening in Alzheimer's Disease.
    Garcia-Leon JA; Caceres-Palomo L; Sanchez-Mejias E; Mejias-Ortega M; Nuñez-Diaz C; Fernandez-Valenzuela JJ; Sanchez-Varo R; Davila JC; Vitorica J; Gutierrez A
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's in 3D culture: challenges and perspectives.
    D'Avanzo C; Aronson J; Kim YH; Choi SH; Tanzi RE; Kim DY
    Bioessays; 2015 Oct; 37(10):1139-48. PubMed ID: 26252541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling neurodegenerative diseases with cerebral organoids and other three-dimensional culture systems: focus on Alzheimer's disease.
    Venkataraman L; Fair SR; McElroy CA; Hester ME; Fu H
    Stem Cell Rev Rep; 2022 Feb; 18(2):696-717. PubMed ID: 33180261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling tau pathology in human stem cell derived neurons.
    Wray S
    Brain Pathol; 2017 Jul; 27(4):525-529. PubMed ID: 28585382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human iPSC-Based Modeling of Central Nerve System Disorders for Drug Discovery.
    Qian L; Tcw J
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33530458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opportunities and challenges for the use of induced pluripotent stem cells in modelling neurodegenerative disease.
    Wu YY; Chiu FL; Yeh CS; Kuo HC
    Open Biol; 2019 Jan; 9(1):180177. PubMed ID: 30958120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.